Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
about
Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle FormulationEvaluation of the use of therapeutic peptides for cancer treatmentThermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma modelThe design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegenerationThe identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients.Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptideFusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer.A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.PGPIPN, a therapeutic hexapeptide, suppressed human ovarian cancer growth by targeting BCL2.Advances in phage display technology for drug discovery.The integration of a Stat3 specific peptide aptamer into the thioredoxin scaffold protein strongly enhances its inhibitory potency.Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides.A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth.VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines.Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.Chemopreventive role of food-derived proteins and peptides: A review.Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.Incrementally increasing the length of a peptide backbone: effect on macrocyclisation efficiency.Investigation of cytotoxicity of negative control peptides versus bioactive peptides on skin cancer and normal cells: a comparative study.Dual role of nanoparticles as drug carrier and drug.A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferation.
P2860
Q28389837-64B99AF4-EB47-4022-ACCD-A02BECAF5B54Q28394194-F0EDA69F-548D-4AF1-AD50-3D4FBAC2ACB3Q29048586-2C777169-66A8-4F79-9FB9-878A84587A23Q30458838-5CBEE950-90D2-4002-AD9D-C413FB7FD1F7Q30460371-65919BF4-22B9-47A9-AA1F-2D0FDBEFFF23Q33626049-4AE6E58F-8B0D-427A-884F-F939310B99DBQ33934743-1164B477-11FD-45DC-AB84-7E4FDAB3B08AQ34353772-78AFF2F9-328B-4198-A00D-8663D951E255Q34490667-B5576773-7D8F-4165-BC71-4044C275BA03Q34673854-A94271A5-1E0F-4F72-A37B-8ED4128FF5DFQ35614190-D084020A-D6E1-43F2-80EB-B71935FA42CCQ35626605-F9E9B171-8054-4105-A1E3-2757EE25C92DQ36344276-4944567C-D192-4174-A654-E9234E28E58EQ36505695-36FC178B-058E-4E81-8EDB-008726A29995Q37211985-7551B338-3055-40CC-A0C9-CC54F4BF1D87Q37560404-1AB535E1-3F8E-43D0-926F-2CBD68AB4C46Q37755594-3BDE52C8-423C-473A-8D35-D2D13C10FBA0Q38028795-655538EB-9670-433D-8EE1-68BFBCEFA1BDQ38632533-A137D3D9-D75E-43CA-85F6-1B00B97A9C47Q38973458-4AC730F0-B07A-4ABB-A5CE-FCE2F947491CQ38988867-C1866987-44C5-4721-AAF2-B715AF37258AQ39292187-7EB270B0-2D26-4C03-8D6E-16E433777E20Q39614059-FF7EF89B-B00B-4821-A630-B513D00269D3Q39737800-C80501F2-7DAE-4D30-991D-2F46CE845290
P2860
Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic peptides for cance ...... d apoptosis-inducing peptides.
@en
Therapeutic peptides for cance ...... d apoptosis-inducing peptides.
@nl
type
label
Therapeutic peptides for cance ...... d apoptosis-inducing peptides.
@en
Therapeutic peptides for cance ...... d apoptosis-inducing peptides.
@nl
prefLabel
Therapeutic peptides for cance ...... d apoptosis-inducing peptides.
@en
Therapeutic peptides for cance ...... d apoptosis-inducing peptides.
@nl
P2093
P2860
P1476
Therapeutic peptides for cance ...... d apoptosis-inducing peptides.
@en
P2093
Drazen Raucher
Gene L Bidwell
Iqbal Massodi
Shama Moktan
P2860
P304
P356
10.1517/17425240903158909
P407
P577
2009-10-01T00:00:00Z